Skip to content
  • Tuesday, 25 August 2026
  • 2:10 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Biotech Sector Sees Major Leaps in Multiomics, Cell Research Accessibility, and Strategic Leadership
Biotech & Genetic Research

Biotech Sector Sees Major Leaps in Multiomics, Cell Research Accessibility, and Strategic Leadership

Jia Lissa Jul 22, 2026 0

The global biotechnology landscape witnessed a week of pivotal advancements, marked by significant strides in multiomics research, enhanced accessibility to…

Read More
Data Science & Bioinformatics

SmolVLM2-2.2B Revolutionizes Local Video Summarization with Consumer Hardware Accessibility

Evan Lee Salim Jul 10, 2026 0

A significant leap in artificial intelligence accessibility has been marked by the release of SmolVLM2-2.2B by Hugging Face on February…

Read More
Biotech & Genetic Research

Takara Bio Unveils Groundbreaking Instrument-Free Spatial Transcriptomics Workflow, Promising Unprecedented Accessibility and Resolution

Jia Lissa Jun 18, 2026 0

SAN FRANCISCO, CA – Takara Bio, a leading developer of life science research tools, has announced the introduction of a…

Read More
Data Science & Bioinformatics

The ‘Entry-Level’ Gatekeeper: Auditing Job Descriptions with Textstat for Enhanced Accessibility and Inclusivity.

Evan Lee Salim May 29, 2026 0

The modern recruitment landscape frequently presents a perplexing paradox: "entry-level" job descriptions laden with dense, impenetrable jargon that inadvertently deter…

Read More
Data Science & Bioinformatics

The Resurgence of Small Language Models: How Compact AI is Redefining Performance and Accessibility

Evan Lee Salim May 21, 2026 0

The landscape of artificial intelligence is undergoing a significant paradigm shift, challenging long-held assumptions about the necessity of massive model…

Read More
Innovative Housing Designs Dramatically Reduce Childhood Illnesses in TanzaniaNew Therapies Usher in Era of Personalised Treatment for Rare Blood CancersSnail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and BeyondDNA Unveils a Hidden Avian Gem: Japan Welcomes a New Bird Species After Decades of Scientific Scrutiny
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ